kleanthis g xanthopoulos  linkedin linkedin main content starts below kleanthis g xanthopoulosbiotechnology pharmaceuticals medical technologylocationla jolla californiaindustrybiotechnologycurrentirras ab laboratori derivati organici spa cerus dmccpreviousbioniz therapeutics biotechnology innovation organization regulus therapeutics inceducationuniv of stockholmwebsitescompany websitecompany websitecompany website connectionsview kleanthis g’s full profile its freeyour colleagues classmates and  million other professionals are on linkedinview kleanthis g’s full profilesummarykleanthis g xanthopoulos phd is a managing general partner at cerus dmcc and formally of the vandel group cerus is a life sciences investment company kleanthis is currently the chairman  ceo of irras ab a commercial stage medical device and drug delivery company he was the founding president  chief executive officer of regulus therapeutics inc from around its formation in  until june  prior to that he was a managing director of enterprise partners venture capital dr xanthopoulos cofounded and served as president and chief executive officer of anadys pharmaceuticals from its inception in  to  and remained a director until its acquisition by roche in  he was vice president at aurora biosciences acquired by vertex pharmaceuticals from  to  dr xanthopoulos participated in the human genome project as a section head of the national human genome research institute from  to  previously he was an associate professor at the karolinska institute stockholm sweden after completing a postdoctoral research fellowship at the rockefeller university new york an onassis foundation scholar dr xanthopoulos received his bsc in biology with honors from aristotle university of thessaloniki greece and received both his msc in microbiology and phd in molecular biology from the university of stockholm sweden dr xanthopoulos is a member of the board of directors of sente inc founder and director zosano pharma inc nasdaq zsan is chairman of the board of directors of apricus biosciences nasdaq apri and member of the board of privately held laboratori derivati organici spa of milan italy italyexperiencechairman  ceoirras abjune  – present  years  monthsirras ab is a commercial stage medical technology company developing breakthrough solutions to meet the challenge of fluid control and management as well as localized drug delivery for a broad range of brain pathologies including strokemember of the board of directorslaboratori derivati organici spajuly  – present  year  monthmilan area italythe companys line of business includes the manufacturing fabricating and processing of drugs in pharmaceutical preparations for human or veterinary usemanaging general partnercerus dmccaugust  – present  yearsinvesting in innovative healthcare companies that have the potential to transform patient carechairman of the board of directorsapricus biosciences incnovember  – present  years  monthsapricus biosciecnes is developing and commercializing novel therapeutics such as vitaros and ryavacofounder member of the boardsente labsjanuary  – present  years  monthssente is a sciencebased cosmetics company incorporating the science of glycosaminoglycans to create a powerful and effective group of innovative skincare productswwwsentelabscommember of the board of directorszosano pharma – present  yearssan francisco bay areachairman of the boardbioniz therapeuticsjanuary  – august   monthsorange county california areamember of the boardbiotechnology innovation organizationseptember  – may   years  monthshelping emerging growth biotechnology companiespresident  ceoregulus therapeutics incnovember  – june   years  monthsdiscovering and developing microrna therapeutics for serious diseasesmember of the boardbiocomjanuary  – december   yearsworking to benefit the trade organization of life sciences companies in south californiageneral partnerenterprise partners venture capitalnovember  – november   year  monthinvesting in start upsfounder president  ceoanadys pharmaceuticals acquired by roche –   yearsbuild the company and shareholder value and oversee its scientific and financial matters languagesswedishfull professional proficiencygreekfull professional proficiencyitalianlimited working proficiencyskillslifesciencesoncologybiopharmaceuticalsmolecular biologystrategic planninginfectious diseasesimmunologyinvestor relationsrdlicensingbusiness developmentbusiness strategypublic companiesstrategic alliancesstrategic partnershipssee product developmentgenomicslife sciencesstartupsbiotechnologyventure capitalrelationshipbuilding skillsmanagementstartupsee lesshows this translationgreat•has errorsthanks for your helpeducationuniv of stockholmphd mol biologyphd mol biology – rockefeller universitycellcellular and molecular biologycellcellular and molecular biology – post doctoral fellow univ of stockholmmaster of science msc microbiology and immunologymaster of science msc microbiology and immunology – aristotle university thessaloniki greecebachelor of applied science basc biologybiological sciences generalbachelor of applied science basc biologybiological sciences general – volunteer experience  causescauses kleanthis g cares aboutenvironmenthealthhuman rightspublicationsover  peer review scientific papersauthors kleanthis g xanthopoulosgroupsbiocomview kleanthis g’s full profile tosee who you know in commonget introducedcontact kleanthis g directlyview kleanthis g’s full profileview this profile in another languageenglishgermanpeople also viewedkonstantinos alataris phdfounder  former ceo nevro corp nyse nvro former president and ceo zosano pharma nasdaq zsan steve worlandpresident and ceo at effector therapeutics incjay shortvioletta akopianvice president pharmaceutical development at regulus therapeuticsbrandy lewissenior director quality assurance at regulus therapeuticsjay haganpresident ceo and director at regulus therapeuticsamit munshinazli azimiceo bioniz therapeuticsdanling wangassociate director at regulus therapeuticsgeorgia erbezchief business officer and chief financial officerpublic profile badgeinclude this linkedin profile on other websitesview profile badgessearch by nameover  million professionals are already on linkedin find who you knowfirst namelast nameexample jeff weinerlinkedin member directoryabcdefghijklmnopqrstuvwxyzmorebrowse members by country xanthopoulos kleanthis g  the wall street transcript kleanthis g xanthopoulos kleanthis g xanthopoulos phd is president and chief executive officer of regulus therapeutics inc dr xanthopoulos joined regulus around its formation in  prior to that he was a managing director of enterprise partners venture capital dr xanthopoulos cofounded and served as president and chief executive officer of anadys pharmaceuticals from its inception in  to  and remained a director until its acquisition by roche in  he was vice president at aurora biosciences — acquired by vertex pharmaceuticals — from  to  dr xanthopoulos participated in the human genome project as a section head of the national human genome research institute from  to  previously he was an associate professor at the karolinska institute stockholm sweden after completing a postdoctoral research fellowship at the rockefeller university new york an onassis foundation scholar dr xanthopoulos received his bs in biology with honors from aristotle university of thessaloniki greece and received both his ms in microbiology and phd in molecular biology from the university of stockholm sweden dr xanthopoulos is a member of the board of directors of the biotechnology industry organization or bio sente inc and zosano pharma inc and is chairman of the board of directors of apricus biosciences related interviewsinterview with the president and ceo regulus therapeutics inc rglsaugust  kleanthis xanthopoulos  anadys pharmaceuticals inc andsoctober  kleanthis xanthopoulos  anadys pharmaceuticals incseptember  kleanthis xanthopoulos  anadys pharmaceuticals incoctober  kleanthis zanthopoulos  anadys pharmaceuticals incseptember   cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsdelivering longterm results with a riskmanaged growth fundjames a abate published july   in investing strategiescompanies covered amat jnj coh rl cog nvda adbe atvi klac amzn nflx goog fb glw mu   wfm jwn cmg gps eqt rice spls buy finding investments with favorable risk and reward opportunitieshenry beukema published july   in investing strategiescompanies covered orcl msft nsrgy amzn wfm lrlcy agn lnr buy better returns and lower risk in the midcap spacemalcolm e polley published july   in investing strategiescompanies covered praa hurn fii fl nke amzn wfm wba rad buy most popular reportswireless communications  telecom published july  buy investing strategies published july  buy investing strategies published june  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsdelivering longterm results with a riskmanaged growth fundfinding investments with favorable risk and reward opportunitiesbetter returns and lower risk in the midcap space analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript  terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google regulus’ kleanthis g xanthopoulos phd to step down as president and chief executive officer regulus kleanthis g xanthopoulos phd to step down as president and chief executive officer  paul grint md appointed as president and chief executive officer and as a member of the board of directors neil w gibson phd to continue as presidents fellow through june th to aid in transition jun    et from regulus therapeutics inc regulus therapeutics inc logo     facebook twitter pinterest regulus therapeutics inc logo la jolla calif june   prnewswire  regulus therapeutics inc nasdaq rgls a biopharmaceutical company leading the discovery and development of innovative medicines targeting micrornas announced today that kleanthis g xanthopoulos phd has resigned as president and chief executive officer and as a member of regulus board of directors effective today to pursue investment opportunities in the biotechnology industry  paul grint md who previously served as chief medical officer of regulus has been appointed as president and chief executive officer and as a member of regulus board of directors effective today  in addition neil w gibson phd who has served as chief scientific officer will continue through june   at the company as presidents fellow to assist dr grint in assembling a new leadership team  i am extremely proud of our achievements at regulus and am excited about the future of the company and microrna therapeutics as they become a new and major class of drugs  rg our galnacconjugated antimir is moving rapidly into phase ii and our clinical map initiative strategy is on track to create multiple clinical programs said kleanthis g xanthopoulos phd paul shares a common vision to continue to build a leading biopharmaceutical company based on our innovative microrna platform across multiple therapeutic areas  i am truly honored to have been a part of building this great company  under kleanthis leadership regulus has grown from a small private company to a rapidly maturing publicly traded biopharmaceutical company with an exciting technology platform multiple strategic alliances and collaborations with leading large pharmaceutical companies and a robust microrna therapeutics pipeline said stelios papadopoulos phd chairman of the board of directors of regulus  we thank kleanthis for his contributions over the last seven years  his passion for building the company and dedication to discovering and developing therapeutics for patients in need have benefited regulus greatly  dr papadopoulos continued we are pleased to appoint paul as president and chief executive officer and believe that he is perfectly positioned to lead the company  he has over two decades of executive level experience in drug development and is a recognized leader in our industry  in particular his appointment is important at this time as the company increases its investment and focus on rg  dr grint also commented i am honored for the opportunity to lead this great company and particularly excited about entering into multiple phase ii studies for rg with critical fourweek combination data coming by yearend  in addition we remain focused on the advancement of the overall portfolio and have many key catalysts on the horizon  in the near term we expect to initiate our firstinhuman clinical study of rg our antimir for the treatment of alport syndrome and we are aggressively pursuing additional attractive microrna targets to expand our leadership in the field  about regulus regulus therapeutics inc nasdaq rgls is a biopharmaceutical company leading the discovery and development of innovative medicines targeting micrornas  regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a wellbalanced microrna therapeutics pipeline complemented by a maturing micromarkerssm biomarkers platform and a rich intellectual property estate to retain its domain dominant leadership in the microrna field  under its clinical map initiative regulus is developing rg a galnacconjugated antimir targeting microrna for the treatment of chronic hepatitis c virus infection and rg an antimir targeting microrna for the treatment of alport syndrome a lifethreatening kidney disease driven by genetic mutations with no approved therapy in addition rg a galnacconjugated antimir targeting microrna for the treatment of nash in patients with type  diabetesprediabetes has been selected for clinical development  regulus is also advancing several programs toward clinical development in orphan disease indications oncology and fibrosis  regulus commitment to innovation has resulted in multiple peerreviewed publications in notable scientific journals and has resulted in the formation of strategic alliances with astrazeneca and sanofi and a research collaboration with biogen focused on microrna biomarkers  regulus maintains its corporate headquarters in la jolla ca  for more information please visit httpwwwregulusrxcom  forwardlooking statements statements contained in this press release regarding matters that are not historical facts are forwardlooking statements within the meaning of the private securities litigation reform act of  including statements associated with the duration of dr gibsons services as presidents fellow the expected ability of regulus to undertake certain activities and accomplish certain goals the projected timeline of clinical development activities and expectations regarding future therapeutic and commercial potential of regulus business plans technologies and intellectual property related to microrna therapeutics and biomarkers being discovered and developed by regulus  because such statements are subject to risks and uncertainties actual results may differ materially from those expressed or implied by such forwardlooking statements words such as believes anticipates plans expects intends will goal potential and similar expressions are intended to identify forwardlooking statements these forwardlooking statements are based upon regulus current expectations and involve assumptions that may never materialize or may prove to be incorrect  actual results and the timing of events could differ materially from those anticipated in such forwardlooking statements as a result of various risks and uncertainties which include without limitation risks associated with the process of discovering developing and commercializing drugs that are safe and effective for use as human therapeutics and in the endeavor of building a business around such drugs  these and other risks concerning regulus financial position and programs are described in additional detail in regulus filings with the securities and exchange commission  all forwardlooking statements contained in this press release speak only as of the date on which they were made regulus undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made logo  httpphotosprnewswirecomprnhlogo   source regulus therapeutics inc related links httpwwwregulusrxcom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more jun    et preview regulus initiates phase i clinical study of rg a microrna therapeutic in development for the treatment of alport syndrome may    et preview regulus reports first quarter  financial results and recent highlights my news release contains wide tables view fullscreen read more jun    et regulus announces pricing of public offering of common stock jun    et regulus announces commencement of public offering of common stock jun    et regulus promotes mark deeg md phd to chief medical officer looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search kleanthis g xanthopoulos  linkedin linkedin main content starts below teile dieses profils können maschinell übersetzt werden die übersetzung kann fehler enthalten übersetzung anzeigenoriginal anzeigenablehnenkleanthis g xanthopoulosbiotechnology pharmaceuticals medical technologystandortla jolla californiabranchebiotechnologieaktuellirras ab laboratori derivati organici spa cerus dmccfrüherbioniz therapeutics biotechnology innovation organization regulus therapeutics incausbildunguniv of stockholmwebseitenunternehmenswebseiteunternehmenswebseiteunternehmenswebseitekontaktesehen sie sich kleanthis g xanthopoulos’ vollständiges profil an es ist kostenlosihre kollegen kommilitonen und  millionen weitere fach und führungskräfte sind bereits auf linkedinkleanthis g xanthopoulos’ vollständiges profil anzeigenzusammenfassungkleanthis g xanthopoulos phd is a managing general partner at cerus dmcc and formally of the vandel group cerus is a life sciences investment company kleanthis is currently the chairman  ceo of irras ab a commercial stage medical device and drug delivery company he was the founding president  chief executive officer of regulus therapeutics inc from around its formation in  until june  prior to that he was a managing director of enterprise partners venture capital dr xanthopoulos cofounded and served as president and chief executive officer of anadys pharmaceuticals from its inception in  to  and remained a director until its acquisition by roche in  he was vice president at aurora biosciences acquired by vertex pharmaceuticals from  to  dr xanthopoulos participated in the human genome project as a section head of the national human genome research institute from  to  previously he was an associate professor at the karolinska institute stockholm sweden after completing a postdoctoral research fellowship at the rockefeller university new york an onassis foundation scholar dr xanthopoulos received his bsc in biology with honors from aristotle university of thessaloniki greece and received both his msc in microbiology and phd in molecular biology from the university of stockholm sweden dr xanthopoulos is a member of the board of directors of sente inc founder and director zosano pharma inc nasdaq zsan is chairman of the board of directors of apricus biosciences nasdaq apri and member of the board of privately held laboratori derivati organici spa of milan italy italyerfahrungchairman  ceoirras abjuni  – heute  jahre  monateirras ab is a commercial stage medical technology company developing breakthrough solutions to meet the challenge of fluid control and management as well as localized drug delivery for a broad range of brain pathologies including strokemember of the board of directorslaboratori derivati organici spajuli  – heute  jahr  monatmailand und umgebung italienthe companys line of business includes the manufacturing fabricating and processing of drugs in pharmaceutical preparations for human or veterinary usemanaging general partnercerus dmccaugust  – heute  jahreinvesting in innovative healthcare companies that have the potential to transform patient carechairman of the board of directorsapricus biosciences incnovember  – heute  jahre  monateapricus biosciecnes is developing and commercializing novel therapeutics such as vitaros and ryavacofounder member of the boardsente labsjanuar  – heute  jahre  monatesente is a sciencebased cosmetics company incorporating the science of glycosaminoglycans to create a powerful and effective group of innovative skincare productswwwsentelabscommember of the board of directorszosano pharma – heute  jahresan francisco bay und umgebungchairman of the boardbioniz therapeuticsjanuar  – august   monateorange county und umgebung kalifornienmember of the boardbiotechnology innovation organizationseptember  – mai   jahre  monatehelping emerging growth biotechnology companiespresident  ceoregulus therapeutics incnovember  – juni   jahre  monatediscovering and developing microrna therapeutics for serious diseasesmember of the boardbiocomjanuar  – dezember   jahreworking to benefit the trade organization of life sciences companies in south californiageneral partnerenterprise partners venture capitalnovember  – november   jahr  monatinvesting in start upsfounder president  ceoanadys pharmaceuticals acquired by roche –   jahrebuild the company and shareholder value and oversee its scientific and financial matters sprachenschwedischswedishoriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfeverhandlungssichergriechischgreekoriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfeverhandlungssicheritalienischitalianoriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfekonversationssicherdummydummyoriginal anzeigenübersetzung anzeigenkenntnisselifesciencesonkologieoncologybiopharmazeutikabiopharmaceuticalsmolekularbiologiemolecular biologystrategische planungstrategic planninginfektionskrankheiteninfectious diseasesimmunologieimmunologyinvestor relationsforschung und entwicklungrdlizenzierunglicensinggeschäftsentwicklungbusiness developmentunternehmensstrategiebusiness strategybörsennotierte unternehmenpublic companiesstrategische allianzenstrategic alliancesstrategische partnerschaftenstrategic partnerships anzeigenproduktentwicklungproduct developmentgenomikgenomicsbiowissenschaftenlife sciencesstartupsbiotechnologiebiotechnologyrisikokapitalventure capitalrelationship  building fähigkeitenrelationshipbuilding skillsunternehmensführungmanagementstartupweniger anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfeausbildunguniv of stockholmphd mol biologyphd mol biology – rockefeller universitätrockefeller universityoriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfezellzellularbiologie und molekularbiologiecellcellular and molecular biologyoriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfe – post doctoral fellow univ of stockholmmaster of science msc mikrobiologie und immunologiemaster of science msc microbiology and immunologyoriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfe – aristotle universität thessaloniki greecearistotle university thessaloniki greeceoriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfebachelor of applied science basc biologiebiologische wissenschaften allgemeinbachelor of applied science basc biologybiological sciences generaloriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfe – ehrenamtthemen die kleanthis g xanthopoulos wichtig sindumweltgesundheitmenschenrechtveröffentlichungenover  peer review scientific papersautoren kleanthis g xanthopoulosgruppenbiocomsehen sie sich kleanthis g xanthopoulos’ vollständiges profil an finden sie heraus welche gemeinsamen kontakte sie habenlassen sie sich vorstellenkontaktieren sie kleanthis g xanthopoulos direktkleanthis g xanthopoulos’ vollständiges profil anzeigenprofil in einer anderen sprache anzeigenenglischdeutschebenfalls angesehenkonstantinos alataris phdfounder  former ceo nevro corp nyse nvro former president and ceo zosano pharma nasdaq zsan steve worlandpresident and ceo at effector therapeutics incjay shortvioletta akopianvice president pharmaceutical development at regulus therapeuticsbrandy lewissenior director quality assurance at regulus therapeuticsjay haganpresident ceo and director at regulus therapeuticsamit munshinazli azimiceo bioniz therapeuticsdanling wangassociate director at regulus therapeuticsgeorgia erbezchief business officer and chief financial officerbadge für ihr öffentliches profildieses linkedin profil auf anderen webseiten verwendenprofilbadges anzeigensuche nach namenüber  millionen fach und führungskräfte sind bereits auf linkedin finden sie heraus wen sie bereits kennenvornamenachnamebeispiel jeff weinerlinkedin mitgliederverzeichnisabcdefghijklmnopqrstuvwxyzmehrmitglieder nach land durchsuchenbeginn der umfrageschließenerweiternwas halten sie von dieser übersetzunghelfen sie dabei die maschinell übersetzten profile von linkedin zu verbessern ist ihnen einer dieser punkte aufgefallen falsches geschlechtunprofessioneller stilformatierungsfehlerfehlerhafte übersetzungwählen sie bitte mindestens eine antwort ausfeedback sendenende der umfragebeginn des dialogsschließendanke für ihre hilfewir verwenden diese informationen zur verbesserung unserer maschinellen übersetzungenende des dialogs xanthopoulos kleanthis g  the wall street transcript kleanthis g xanthopoulos kleanthis g xanthopoulos is the president and ceo of anadys pharmaceuticals inc previously he was a vice president of genomics and molecular biology at aurora biosciences corp where he developed and commercialized aurora’s genomics business dr xanthopoulos was a section head of the national human genome research institute at nih and he is currently an adjunct associate professor at the university of utah medical school salt lake city previously he held an associate professorship at the karolinska nobel medical institute stockholm sweden dr xanthopoulos graduated from the aristotle university of thessaloniki greece and received both his msc in microbiology and phd in molecular biology from the university of stockholm sweden he is an onassis scholar a greek government distinguished fellow the recipient of swedish national sciences foundation awards and was a national institutes of health fellow at the rockefeller university new york he is also the author of more than  peer review publications and a member of several editorial boards related interviews cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsdelivering longterm results with a riskmanaged growth fundjames a abate published july   in investing strategiescompanies covered amat jnj coh rl cog nvda adbe atvi klac amzn nflx goog fb glw mu   wfm jwn cmg gps eqt rice spls buy finding investments with favorable risk and reward opportunitieshenry beukema published july   in investing strategiescompanies covered orcl msft nsrgy amzn wfm lrlcy agn lnr buy better returns and lower risk in the midcap spacemalcolm e polley published july   in investing strategiescompanies covered praa hurn fii fl nke amzn wfm wba rad buy most popular reportswireless communications  telecom published july  buy investing strategies published july  buy investing strategies published june  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsdelivering longterm results with a riskmanaged growth fundfinding investments with favorable risk and reward opportunitiesbetter returns and lower risk in the midcap space analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript  terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google anadys pharmaceuticals inc s kleanthis g xanthopoulos ph d to step down as president ceo by year end to join san diego vc firm employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       anadys pharmaceuticals inc andss kleanthis g xanthopoulos phd to step down as president  ceo by yearend to join san diego vc firm tweet   pm san diego june  prnewswirefirstcall  anadys pharmaceuticals inc nasdaq ands  news announced today that kleanthis g xanthopoulos phd is resigning as president and chief executive officer effective at the end of  or sooner if a successor has been identified and appointed he will join san diegobased enterprise partners venture capital as a managing director dr xanthopoulos will continue to serve as a board member of anadys following his resignation as president and chief executive officer anadys will initiate a search for a new president and chief executive officer in addition the company has promoted steve worland phd to the newly created post of president pharmaceuticals from executive vice president pharmaceuticals kleanthis is an entrepreneur whose passion for building anadys and cultivating the leadership team is evident in all aspects of his work said george a scangos phd the companys chairman he will continue to have an integral role in the setting of anadys strategic direction as a member of our board the end of the year is the right time for him to make the move given the companys strong position in his new role he will be able to share his visionary thinking and operations expertise with other entrepreneurs in the life sciences industry although we will miss his inspirational leadership at anadys we are happy to see him continuing to contribute as a board member dr xanthopoulos commented i am proud of our accomplishments at anadys and excited about our current clinical programs and deep pipeline i am also excited about continuing to help shape anadys from a position on the board as well as in having the opportunity to provide other entrepreneurs with counsel in my future role in venture capital steve and the other members of our team share a common vision in building a leading pharmaceutical franchise with a focus on antivirals and cancer drugs i am honored to be part of that new position  president pharmaceuticals in his new position dr worland will lead all of anadys strategic planning corporate development and research  development efforts he has been involved with the development and implementation of the companys strategic plan since joining anadys in  as chief scientific officer dr worland was promoted to executive vice president head of research and development in october  in december  he was named executive vice president pharmaceuticals prior to anadys he was vice president head of antiviral research at agouron pharmaceuticals a pfizer company he received a bs degree in biological chemistry from the university of michigan and a phd in chemistry from the university of california berkeley he was a national institutes of health postdoctoral fellow in molecular biology at harvard university from  to  steves contributions have been critical to our successes on both the scientific and business fronts including our landmark collaboration with novartis dr xanthopoulos said his promotion will enable him to expand his leadership role with the company webcast of conference call anadys will host a conference call tomorrow june   at  am eastern daylight time to discuss anadys executive transition a live webcast of the call is available online at wwwanadyspharmacom a telephone replay will also be available approximately one hour after completion of the call to access the telephone replay dial  domestic or  international passcode  the webcast and telephone replay will be available through june   about anadys anadys pharmaceuticals inc wwwanadyspharmacom is a biopharmaceutical company committed to advancing patient care by discovering developing and commercializing novel small molecule medicines for the treatment of hepatitis other serious infections and cancer the company has core expertise in tolllike receptorbased small molecule therapeutics and structurebased drug design coupled with medicinal chemistry anadys clinical development programs include ana for the treatment of hcv and hbv and ana for the treatment of hbv in addition anadys therapeutic platform is designed to advance a strong and continual pipeline of drug candidates into the clinic safe harbor statement statements in this press release that are not strictly historical in nature constitute forwardlooking statements such forwardlooking statements involve known and unknown risks uncertainties and other factors which may cause anadys actual results to be materially different from historical results or from any results expressed or implied by such forwardlooking statements in particular the results of initial clinical trials may not be predictive of future results and anadys cannot provide any assurances that any of its product candidates will have favorable results in future clinical trials or receive regulatory approval in addition anadys results may be affected by risks related to its collaborative relationships with novartis and lg life sciences competition from other biotechnology and pharmaceutical companies its effectiveness at managing its financial resources its ability to successfully develop and market products the level of effort that its collaborative partners devote to development and commercialization of its product candidates difficulties or delays in its clinical trials difficulties or delays in manufacturing its clinical trials materials the scope and validity of patent protection for its products regulatory developments involving future products and its ability to obtain additional funding to support its operations these and other factors that may cause actual results to differ are more fully discussed in the risk factors section of anadys form q for the quarter ended march   all forwardlooking statements are qualified in their entirety by this cautionary statement anadys is providing this information as of this date and does not undertake any obligation to update any forwardlooking statements contained in this document as a result of new information future events or otherwise source anadys pharmaceuticals inc read at biospacecom read at reuters related news anadys pharmaceuticals inc ands and lg life sciences ltd release completion of ana dosing in phase ii clinical trial confirms robust activity against lamivudineresistant hepatitis b virus nps pharmaceuticals inc npsp announces aggressive plan to restructure operations and cut costs reducing staff by  anadys pharmaceuticals inc ands reports first quarter  financial results panacos pharmaceuticals inc panc president and ceo samuel k ackerman dies suddenly at age  anadys pharmaceuticals inc ands to report first quarter  financial results penwest pharmaceutical ppco names jennifer good chief executive officer and member of the board of directors kleanthis g xanthopoulos phd ceo of anadys pharmaceuticals inc ands to join enterprise partners as a managing director by yearend amgen amgn to triple japan staff to sell drugs on its own anadys pharmaceuticals inc ands release robust viral load reduction successfully achieved in phase ii clinical trial of ana in lamivudine scheringplough corporation sgp announces changes to manufacturing operations to cut  jobs please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • reuters • anadys pharmaceuticals inc   • biotechpharma  personnel                 kleanthis xanthopoulos senté glycosaminoglycan board member physicianfinder t s httpswwwfacebookcomsenteskin httpstwittercomsentescience httpswwwinstagramcomsenteskincare httpswwwpinterestcomsentecream httpswwwlinkedincomcompanytrktyah senté search for skip to contentkleanthis g xanthopoulos phdkleanthis g xanthopoulos phddr xanthopoulos is currently the executive chairman of irras ab a commercial stage medical device and drug delivery company and managing partner at the vandelgroup focusing on investing and building innovative biotechnology companies dr xanthopoulos served as president and chief executive officer of regulus therapeutics inc nasdaq rgls from the time of its formation in  until june of  prior to that he was a managing director of enterprise partners venture capital dr xanthopoulos cofounded and served as president and chief executive officer of anadys pharmaceuticals inc nasdaq ands from its inception in  to  and remained a director until its acquisition by roche in  he was vice president at aurora biosciences acquired by vertex pharmaceuticals inc from  to  dr xanthopoulos participated in the human genome project as a section head of the national human genome research institute from  to  prior to this he was an associate professor at the karolinska institute stockholm sweden after completing a postdoctoral research fellowship at the rockefeller university new york an onassis foundation scholar he was named the ey entrepreneur of the year in  in san diego and the san diego business journal’s most admired midsize company ceo in   dr xanthopoulos received his bsc in biology with honors from aristotle university of thessaloniki greece and received both his msc in microbiology and phd in molecular biology from the university of stockholm swedenin addition to his role at irras ab dr xanthopoulos is chairman of the board of directors of apricus biosciences nasdaq apri a director of zosano pharma inc nasdaq zsan and a director of ldo spa milan italynext read about marios fotiadisbefore  after  beforeafterbalarger beforeafterbalarger beforeafterbalarger beforeafterbalarger beforeafterbalarger beforeafterbalargerwhat the experts are saying jody comstock mdjody comstock md  skin spectrum tucson az view testimonials let us call you back xcontact senté find where to buy get social with us httpswwwfacebookcomsenteskincare httpstwittercomsenteskincare httpswwwinstagramcomsenteskincare httpswwwpinterestcomsentescience httpswwwlinkedincomcompanytrktyah contact us kleanthis g xanthopoulos phd  irras menu kleanthis g xanthopoulos phd irraflowtm  practical solutions to intelligent fluid management for brain pathology therapeutics irraflowtm kleanthis g xanthopoulos phdchairman  ceo back kleanthis g xanthopoulos phd is a serial entrepreneur whose passion is building healthcare companies focused on innovation dr xanthopoulos has over two decades of experience in the biotechnology and pharmaceutical research industries as an executive company founder chief executive officer investor and board member dr xanthopoulos has founded three companies has introduced two life science companies to nasdaq and has financed and brokered numerous creative strategic alliance and partnership deals with large pharmaceutical partners dr xanthopoulos is currently the executive chairman of irras ab a commercial stage medical device and drug delivery company and managing general partner at cerus dmcc which focuses on investing and building innovative biotechnology companies dr xanthopoulos served as president and chief executive officer of regulus therapeutics inc nasdaq rgls from the time of its formation in  until june of  prior to that he was a managing director of enterprise partners venture capital dr xanthopoulos cofounded and served as president and chief executive officer of anadys pharmaceuticals inc nasdaq ands from its inception in  to  and remained a director until its acquisition by roche in  he was vice president at aurora biosciences acquired by vertex pharmaceuticals inc from  to  dr xanthopoulos participated in the human genome project as a section head of the national human genome research institute from  to  prior to this he was an associate professor at the karolinska institute stockholm sweden after completing a postdoctoral research fellowship at the rockefeller university new york an onassis foundation scholar he was named the ey entrepreneur of the year in  in san diego and the san diego business journal’s most admired midsize company ceo in  dr xanthopoulos received his bsc in biology with honors from aristotle university of thessaloniki greece and received both his msc in microbiology and phd in molecular biology from the university of stockholm sweden in addition to his role at irras ab dr xanthopoulos is chairman of the board of directors of apricus biosciences nasdaq apri a director of zosano pharma inc nasdaq zsan a director of ldo spa milan italy and is the cofounder and a member of the board of directors of privately held sente inc and aspius inc kleanthis g xanthopoulos phd executive profile  biography  bloomberg july    am et pharmaceuticals company overview of irras ab snapshotpeople  overviewboard memberscommittees executive profile kleanthis g xanthopoulos phdexecutive chairman and acting chief executive officer irras abagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background dr kleanthis g xanthopoulos phd serves as an executive chairman and acting chief executive officer at irras ab dr xanthopoulos serves as the managing director of life science investments at novera optics inc he served as the chief executive officer and president of regulus therapeutics inc from january  to june  and previously served same positions since december  dr xanthopoulos also served as principal financial  accounting officer of regulus  therapeutics inc since june   he served as senior vice president and vice president at ionis pharmaceuticals inc alternate name isis pharmaceuticals inc dr xanthopoulos has over two decades of experience in the biotechnology and pharmaceutical research industries as an executive he founded sente inc and served as its chief executive officer and president he served as the president and chief executive officer at regulus therapeutics llc since joining in december  he joined regulus in  he served as a managing director at enterprise partners venture capital since june  dr xanthopoulos cofounded anadys pharmaceuticals inc in may  and served as its president and chief executive officer from  to november  from  to  he served as vice president of genomics  molecular biology at aurora biosciences corporation from  to  he participated in the national institutes of health human genome project and served as a section head of the national human genome research institute from  to  dr xanthopoulos has been the chairman of apricus biosciences inc since december   and has been its director since november   he served as the chairman of the board at bioniz therapeutics inc from  to july   he served as chairman of the board of bioniz llc since january   he has been an independent director of zosano pharma corporation since april  he serves as an executive director of regulus therapeutics llc dr xanthopoulos serves as a member of the executive board at biocom inc he serves as a director of zp holdings inc biocom sa southern californias life science industry association biotechnology innovation organization formerly biotechnology industry organization and sente inc he served as a director of regulus therapeutics inc from january  to june   he served as a director of anadys pharmaceuticals inc from may  to november   and zosano inc from october   to april   he served as a director of odyssey thera inc he served as a director of bioniz llc from  to august   he served as an associate professor of molecular biology at the karolinska nobel medical institute stockholm sweden from  to  and postdoctoral research fellow at the rockefeller university from  to  an onassis scholar dr xanthopoulos received bsc in biology with honors from aristotle university of thessaloniki greece and received both his msc in microbiology and phd in molecular biology from the university of stockholm swedenread full background corporate headquarters kungsgatan stockholm stockholm county swedenphone fax  board members memberships directorbiocom sadirectorbiotechnology innovation organizationfounder and directorsente incexecutive chairman and acting chief executive officerirras abpresentchairman of the boardapricus biosciences incpresentindependent directorzosano pharma corporation education ms stockholms universitetphd stockholms universitetbs university of thessaloniki other affiliations enterprise partners venture capitalaurora biosciences corporationionis pharmaceuticals incanadys pharmaceuticals incbiocom saapricus biosciences incodyssey thera incnovera optics incnational institutes of healthbiotechnology innovation organizationstockholms universitetuniversity of thessalonikibiocom incnational human genome research institutezosano pharma corporationregulus therapeutics incsente incbioniz llcjem capital inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact irras ab please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close bioniz names veteran biotech leader kleanthis g xanthopoulos phd as chairman of its board of bioniz names veteran biotech leader kleanthis g xanthopoulos phd as chairman of its board of directors jan    et from bioniz therapeutics inc bioniz names veteran biotech leader kleanthis g xanthopoulos phd as chairman of its board of directors     facebook twitter pinterest bioniz names veteran biotech leader kleanthis g xanthopoulos phd as chairman of its board of directors irvine calif jan   prnewswire  bioniz therapeutics inc a biopharmaceutical company developing firstinclass multicytokine inhibitory therapeutics to address immunoinflammatory diseases and cancer announced today that is has named kleanthis g xanthopoulos phd as chairman of its board of directors  dr xanthopoulos who joined the bioniz board of directors in  is a serial entrepreneur and worldrenowned luminary in the biotechnology and pharmaceutical industries with significant operational and corporate development expertise  in addition to dr xanthopoulos bionizs board consists of industry legends david pyott former chairman and chief executive officer of allergan inc joe kiani founder chairman and ceo of masimo corporation and renowned biotechnology venture capital leader ilan zipkin phd senior investment director of takeda ventures inc kleanthis has been instrumental in successfully starting and growing multiple biotechnology companies and his transition to chairman of the board is ideal for bioniz at this stage in its growth said david pyott strategic investor and member of the board of directors of bioniz with kleanthis leadership we seek to maximize the potential of the firstinclass multicytokine inhibitory therapeutics platform and sharpen the companys strategic focus and operational execution bioniz has a unique opportunity to transform the field of drug discovery by creating drugs that target more than one diseasedriving cytokine at a time to treat immunoinflammatory diseases and cancer said dr xanthopoulos  i am excited to support and guide the dedicated management team and very accomplished board to grow bioniz into a leading biotechnology organization dr nazli azimi founder and ceo of bioniz commented we are extremely pleased to name kleanthis as chairman  kleanthis wealth of executive leadership experience scientific creativity and trusted business acumen will enhance the companys opportunity to pioneer a new and major class of drugs dr xanthopoulos is currently the executive chairman of irras ab an emerging medical device and drug delivery company and a partner at the vandelgroup focused on investing and building innovative companies  previously dr xanthopoulos served as president and chief executive officer and a member of the board of directors of regulus therapeutics inc from the time of its formation in  until june  prior to that he was a managing director of enterprise partners venture capital dr xanthopoulos cofounded and served as president and chief executive officer of anadys pharmaceuticals inc from its inception in  to  and remained a director until its acquisition by roche in  before forming anadys dr xanthopoulos was vice president at aurora biosciences acquired by vertex pharmaceuticals from  to  and section head of the national human genome research institute from  to  he was an associate professor at the karolinska institute stockholm sweden after completing a postdoctoral research fellowship at the rockefeller university new york  an onassis foundation scholar dr xanthopoulos received his bsc in biology with honors from aristotle university of thessaloniki greece and his msc degree in microbiology and phd degree in molecular biology from the university of stockholm sweden dr xanthopoulos is chairman of the board of directors of apricus biosciences a member of the board of directors of the biotechnology industry organization bio and zosano pharma inc and is a cofounder and a member of the board of directors of sente inc a privately held specialty aesthetics company additionally dr xanthopoulos received the ernst  young entrepreneur of the year award in health sciences in  and was named most admired ceo by the san diego business journal in  about bioniz bioniz therapeutics is a biopharmaceutical company leading the discovery and development of firstinclass multicytokine inhibitory therapeutics to address immunoinflammatory diseases and cancer with an initial focus on orphan diseases that have an immune component bioniz leverages a world class expertise in cytokine biology originating in research conducted at the national institute of health to create a therapeutic platform based on a new generation of multiplecytokine inhibitors with selective specificity selective targeting of multiple cytokines that have redundant functions improves on the traditional approach of single anticytokine therapy and therefore increases the therapeutic potential of bioniz compounds  bionizs technology is protected by us and international patents and are solely owned by bioniz for more information please visit wwwbionizcom contact david eichhorndavideichhornbionizcom photo  httpphotosprnewswirecomprnh   source bioniz therapeutics inc view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more may    et preview bioniz therapeutics appoints fredrik wiklund as chief operating officer my news release contains wide tables view fullscreen read more jul    et bioniz therapeutics reports topline phase  clinical study more news releases in biotechnology health care  hospitals medical pharmaceuticals pharmaceuticals personnel announcements looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft kleanthis xanthopoulos  netfind content results aol search skip over navigation search the web web web content anyones history  anyones past available online ad · recordstruthfindercom anyones past available online simply search a name and state learn more search arrest records search records now best people search list of greeks vougiouklaki andréas voutsinas nikos xanthopoulos voula zouboulaki adventurers constantine phaulkon – first counsellor of king narai of siam athletes  sports figures more go to encyclopedia results from the wowcom content network why regulus therapeutics is poised to keep plunging httpswwwaolcomwhyregulustherapeuticsispoised ceo dr kleanthis xanthopoulos since  coo dr garry menzel since  trailingmonth return on equity  cashdebt  million    regulus therapeutics  wowcom wwwwowcomwikiregulustherapeutics regulus therapeutics inc or regulus nasdaq rgls is a biopharmaceutical company focused on the development of micrornabased drugs targeting fibrosis metabolism  alketas panagoulias  wowcom wwwwowcomwikialkispanagoulias alketas panagoulias  the side street adjacent to aris thessaloniki fc stadium kleanthis vikelidis stadium   xanthopoulos   aris bc  wowcom wwwwowcomwikiaristhessalonikibc aris bc was founded in   edgar jones igor moraitis theodosis paralikas kleanthis gallos tasos kotzagkiaouridis  vassilis xanthopoulos tasos  dinos kouis  wowcom wwwwowcomwikidinoskouis dinos kouis greek ντίνος  he made his debut on  october  in derby against paok stadium kleanthis vikelidis stadium   xanthopoulos   list of greeks  wowcom wwwwowcomwikilistofgreeks  list of greeks who were born outside modern greece  nikos xanthopoulos voula zouboulaki  kleanthis vikelides football player – paok fc season  wowcom wwwwowcomwiki–paokfcseason  xanthopoulos stadium toumba stadium attendance   stadium kleanthis vikelidis stadium attendance  referee michailidis  third round alketas panagoulias  wowcom wwwwowcomwikialketaspanagoulias alketas panagoulias date of birth   may  kleanthis vikelidis stadium   xanthopoulos   anyones history  anyones past available online ad · recordstruthfindercom anyones past available online simply search a name and state learn more search arrest records search records now best people search searches related tokleanthis xanthopoulos xanthopoulos vandel group kleanthis regulus news regulus press release related searches xanthopoulos vandel group kleanthis regulus news regulus press release search the web  aol inc all rights reservedprivacy   terms of use   preferences   contact us   powered by bing™ wowcom  part of the aol search network background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming we also search social networks this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip